Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AGNPF
Recent news which mentions AGNPF
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Tickers
AGNPF
ATAI
CMND
CMPS
Tags
Psychedelics Research
IXHL
CMPS
From
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Tickers
AGNPF
Tags
Human Stroke
DMT/Assisted Therapy
Psychedelics Research
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
Legal
CMPS
Psychedelic/Assisted Therapies
From
Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
August 08, 2023
Tickers
AGNPF
Tags
premium
Algernon NeuroScience
Benzinga
From
Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
June 05, 2023
Tickers
AGNPF
Tags
Management
Human Stroke
Psychedelic/Assisted Therapies
From
Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
April 04, 2023
Tickers
AGNPF
CMND
PSYGF
Tags
News
Penny Stocks
Market News
From
Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
April 04, 2023
Tickers
AGNPF
Tags
Cannabis
Market News
Markets
From
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
Tickers
AGNPF
AWKNF
BRAXF
CMPS
Tags
Legal
DOSEF
CMPS
From
Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
March 03, 2023
Tickers
AGNPF
Tags
Benzinga
Penny Stocks
AGNPF
From
Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
March 01, 2023
Tickers
AGNPF
IPOS
Tags
Market News
Stock Split
Cannabis
From
Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
Tickers
AGNPF
AWKNF
CMND
CYBN
Tags
Global
Sector ETFs
AGNPF
From
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Tickers
AGNPF
AWKNF
CYBN
DMTTF
Tags
News
Earnings
FLHLF
From
Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
February 21, 2023
Tickers
AGNPF
TBI
Tags
Health Care
Penny Stocks
News
From
Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
February 16, 2023
Tickers
AGNPF
Tags
Penny Stocks
Health Care
News
From
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
January 18, 2023
Tickers
AGNPF
DMT
Tags
Psychedelics
Benzinga
Human Stroke
From
Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
January 03, 2023
Tickers
AGNPF
Tags
News
MindBio Therapeutics Corp/
Penny Stocks
From
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
December 15, 2022
Tickers
AGNPF
ATAI
FLHLF
Tags
Benzinga
Management
Benjamin Lightburn
From
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Tickers
AGNPF
BMNDF
CMND
CMPS
Tags
TSLA
MYCOF
Market News
From
Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
November 16, 2022
Tickers
AGNPF
Tags
Penny Stocks
News
Cannabis
From
Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
October 24, 2022
Tickers
AGNPF
Tags
AGNPF
Markets
Cannabis
From
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
Tickers
AGNPF
DMT
Tags
AGNPF
Markets
Cannabis
From
Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
September 08, 2022
Tickers
AGNPF
Tags
Psychedelics
Benzinga
Stroke
From
Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
August 23, 2022
Tickers
AGNPF
Tags
Benzinga
Psychedelics
GRA Enterprises
From
Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
July 18, 2022
Tickers
AGNPF
Tags
AGNPF
Market News
General
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
RVVTF
AWKNF
HSTRF
From
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
AGNPF
GTSIF
CLABF
From
Benzinga
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
September 13, 2021
Tickers
AGNPF
ALID
ATAI
FTRP
Tags
Clerkenwell Health
ALID
Benzinga
From
Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
August 02, 2021
Tickers
AGNPF
ATOS
GILD
LLY
Tags
Stocks to Sell
SRNE
NASDAQ:ATOS, NYSE:LLY,OTC:AGNPF,NASDAQ:SRNE,NASDAQ:GILD
From
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.